Journal article
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial
Abstract
Percutaneous coronary intervention (PCI) remains a major therapeutic option for the treatment of chronic coronary artery disease. In the COURAGE trial, 2287 patients with chronic coronary disease were randomized between PCI with medical management and medical management alone. Embedded within the COURAGE trial is a detailed economic analysis being conducted in three health care systems: the US Veterans Administration (VA), Canada, and the US …
Authors
Weintraub WS; Barnett P; Chen S; Hartigan P; Casperson P; O'Rourke R; Boden WE; Lewis C; Veledar E; Becker E
Journal
American Heart Journal, Vol. 151, No. 6, pp. 1180–1185
Publisher
Elsevier
Publication Date
June 2006
DOI
10.1016/j.ahj.2005.07.035
ISSN
0002-8703